AU2007287201B2 - Devices and methods for altering eating behavior - Google Patents
Devices and methods for altering eating behavior Download PDFInfo
- Publication number
- AU2007287201B2 AU2007287201B2 AU2007287201A AU2007287201A AU2007287201B2 AU 2007287201 B2 AU2007287201 B2 AU 2007287201B2 AU 2007287201 A AU2007287201 A AU 2007287201A AU 2007287201 A AU2007287201 A AU 2007287201A AU 2007287201 B2 AU2007287201 B2 AU 2007287201B2
- Authority
- AU
- Australia
- Prior art keywords
- tissue
- tether
- stomach
- device body
- anchoring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000020595 eating behavior Effects 0.000 title claims abstract description 28
- 238000000034 method Methods 0.000 title claims description 54
- 238000004873 anchoring Methods 0.000 claims description 160
- 210000002784 stomach Anatomy 0.000 claims description 155
- 210000001187 pylorus Anatomy 0.000 claims description 144
- 210000001198 duodenum Anatomy 0.000 claims description 94
- 230000002183 duodenal effect Effects 0.000 claims description 27
- 230000002572 peristaltic effect Effects 0.000 claims description 12
- 229920000642 polymer Polymers 0.000 claims description 10
- 230000000149 penetrating effect Effects 0.000 claims description 8
- 238000010992 reflux Methods 0.000 claims description 4
- 230000000903 blocking effect Effects 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 43
- 230000006870 function Effects 0.000 abstract description 20
- 210000001519 tissue Anatomy 0.000 description 235
- 241000282887 Suidae Species 0.000 description 43
- 239000000463 material Substances 0.000 description 36
- 210000003205 muscle Anatomy 0.000 description 36
- 229920001296 polysiloxane Polymers 0.000 description 33
- 230000002496 gastric effect Effects 0.000 description 31
- 210000004913 chyme Anatomy 0.000 description 26
- 238000002513 implantation Methods 0.000 description 26
- 235000013305 food Nutrition 0.000 description 25
- 230000033001 locomotion Effects 0.000 description 25
- 230000007246 mechanism Effects 0.000 description 24
- 210000004876 tela submucosa Anatomy 0.000 description 20
- 238000013459 approach Methods 0.000 description 19
- 239000013543 active substance Substances 0.000 description 18
- 239000003814 drug Substances 0.000 description 18
- 230000030136 gastric emptying Effects 0.000 description 18
- 239000007787 solid Substances 0.000 description 18
- 208000012647 Pseudodiverticular disease Diseases 0.000 description 16
- 229940079593 drug Drugs 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 230000003628 erosive effect Effects 0.000 description 16
- 210000005070 sphincter Anatomy 0.000 description 15
- 239000002253 acid Substances 0.000 description 14
- 230000005291 magnetic effect Effects 0.000 description 14
- 229910052751 metal Inorganic materials 0.000 description 14
- 239000002245 particle Substances 0.000 description 14
- 239000002184 metal Substances 0.000 description 13
- 208000008589 Obesity Diseases 0.000 description 12
- 230000008602 contraction Effects 0.000 description 12
- 235000020824 obesity Nutrition 0.000 description 12
- 230000000638 stimulation Effects 0.000 description 12
- 238000001356 surgical procedure Methods 0.000 description 12
- 230000014759 maintenance of location Effects 0.000 description 10
- 210000004877 mucosa Anatomy 0.000 description 10
- 230000036186 satiety Effects 0.000 description 10
- 235000019627 satiety Nutrition 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 239000011701 zinc Substances 0.000 description 10
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- 210000000412 mechanoreceptor Anatomy 0.000 description 9
- 210000004203 pyloric antrum Anatomy 0.000 description 9
- 229910052725 zinc Inorganic materials 0.000 description 9
- -1 CCK Chemical compound 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 235000005686 eating Nutrition 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000007789 gas Substances 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- 230000029087 digestion Effects 0.000 description 6
- 208000035475 disorder Diseases 0.000 description 6
- 239000013013 elastic material Substances 0.000 description 6
- 230000037406 food intake Effects 0.000 description 6
- 230000001939 inductive effect Effects 0.000 description 6
- 230000000670 limiting effect Effects 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 108091008704 mechanoreceptors Proteins 0.000 description 6
- 210000004400 mucous membrane Anatomy 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000004580 weight loss Effects 0.000 description 6
- 206010059186 Early satiety Diseases 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 230000009471 action Effects 0.000 description 5
- 229910045601 alloy Inorganic materials 0.000 description 5
- 239000000956 alloy Substances 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 210000004211 gastric acid Anatomy 0.000 description 5
- 230000030135 gastric motility Effects 0.000 description 5
- 238000003780 insertion Methods 0.000 description 5
- 230000037431 insertion Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000005298 paramagnetic effect Effects 0.000 description 5
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- 229910000831 Steel Inorganic materials 0.000 description 4
- 235000019789 appetite Nutrition 0.000 description 4
- 230000036528 appetite Effects 0.000 description 4
- 239000002775 capsule Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 4
- 229910001000 nickel titanium Inorganic materials 0.000 description 4
- 210000002747 omentum Anatomy 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 229920002379 silicone rubber Polymers 0.000 description 4
- 210000000813 small intestine Anatomy 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- 230000004936 stimulating effect Effects 0.000 description 4
- 235000019786 weight gain Nutrition 0.000 description 4
- 230000004584 weight gain Effects 0.000 description 4
- 102100033367 Appetite-regulating hormone Human genes 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- 206010016654 Fibrosis Diseases 0.000 description 3
- 101800001586 Ghrelin Proteins 0.000 description 3
- 206010021518 Impaired gastric emptying Diseases 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 239000000919 ceramic Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 210000003238 esophagus Anatomy 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000003925 fat Substances 0.000 description 3
- 230000008713 feedback mechanism Effects 0.000 description 3
- 230000004761 fibrosis Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000003054 hormonal effect Effects 0.000 description 3
- 238000003384 imaging method Methods 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 210000000111 lower esophageal sphincter Anatomy 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 108091008709 muscle spindles Proteins 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 239000004945 silicone rubber Substances 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 2
- 206010004542 Bezoar Diseases 0.000 description 2
- 208000030814 Eating disease Diseases 0.000 description 2
- 208000019454 Feeding and Eating disease Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 206010054949 Metaplasia Diseases 0.000 description 2
- 208000008469 Peptic Ulcer Diseases 0.000 description 2
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 244000258044 Solanum gilo Species 0.000 description 2
- 108010003205 Vasoactive Intestinal Peptide Proteins 0.000 description 2
- 102400000015 Vasoactive intestinal peptide Human genes 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000004026 adhesive bonding Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 235000021052 average daily weight gain Nutrition 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 208000006766 bile reflux Diseases 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 235000021051 daily weight gain Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000014632 disordered eating Nutrition 0.000 description 2
- 230000005611 electricity Effects 0.000 description 2
- 238000002674 endoscopic surgery Methods 0.000 description 2
- 238000013265 extended release Methods 0.000 description 2
- 238000001125 extrusion Methods 0.000 description 2
- 235000012631 food intake Nutrition 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 210000003736 gastrointestinal content Anatomy 0.000 description 2
- 208000001288 gastroparesis Diseases 0.000 description 2
- GNKDKYIHGQKHHM-RJKLHVOGSA-N ghrelin Chemical compound C([C@H](NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CN)COC(=O)CCCCCCC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C1=CC=CC=C1 GNKDKYIHGQKHHM-RJKLHVOGSA-N 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 208000009322 hypertrophic pyloric stenosis Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 238000011068 loading method Methods 0.000 description 2
- 230000015689 metaplastic ossification Effects 0.000 description 2
- 230000004899 motility Effects 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000000926 neurological effect Effects 0.000 description 2
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 208000011906 peptic ulcer disease Diseases 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 239000004814 polyurethane Substances 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000007779 soft material Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 238000011477 surgical intervention Methods 0.000 description 2
- 239000003356 suture material Substances 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 238000009827 uniform distribution Methods 0.000 description 2
- DBGIVFWFUFKIQN-VIFPVBQESA-N (+)-Fenfluramine Chemical compound CCN[C@@H](C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-VIFPVBQESA-N 0.000 description 1
- WZUVPPKBWHMQCE-XJKSGUPXSA-N (+)-haematoxylin Chemical compound C12=CC(O)=C(O)C=C2C[C@]2(O)[C@H]1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-XJKSGUPXSA-N 0.000 description 1
- ALVZYHNBPIMLFM-UHFFFAOYSA-N 2-[4-[2-(4-carbamimidoylphenoxy)ethoxy]phenyl]-1h-indole-6-carboximidamide;dihydrochloride Chemical compound Cl.Cl.C1=CC(C(=N)N)=CC=C1OCCOC1=CC=C(C=2NC3=CC(=CC=C3C=2)C(N)=N)C=C1 ALVZYHNBPIMLFM-UHFFFAOYSA-N 0.000 description 1
- LVRVABPNVHYXRT-BQWXUCBYSA-N 52906-92-0 Chemical compound C([C@H](N)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)C(C)C)C1=CC=CC=C1 LVRVABPNVHYXRT-BQWXUCBYSA-N 0.000 description 1
- OJSXICLEROKMBP-FFUDWAICSA-N 869705-22-6 Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(N)=O)C(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 OJSXICLEROKMBP-FFUDWAICSA-N 0.000 description 1
- 244000226021 Anacardium occidentale Species 0.000 description 1
- 241000949648 Angulus Species 0.000 description 1
- 208000032841 Bulimia Diseases 0.000 description 1
- 206010006550 Bulimia nervosa Diseases 0.000 description 1
- YNXLOPYTAAFMTN-SBUIBGKBSA-N C([C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)C1=CC=C(O)C=C1 Chemical compound C([C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)C1=CC=C(O)C=C1 YNXLOPYTAAFMTN-SBUIBGKBSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000011231 Crohn disease Diseases 0.000 description 1
- 208000008279 Dumping Syndrome Diseases 0.000 description 1
- 108010092674 Enkephalins Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Natural products C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 108010092277 Leptin Proteins 0.000 description 1
- 102000016267 Leptin Human genes 0.000 description 1
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 101710151321 Melanostatin Proteins 0.000 description 1
- 102000002419 Motilin Human genes 0.000 description 1
- 101800002372 Motilin Proteins 0.000 description 1
- 241000238367 Mya arenaria Species 0.000 description 1
- 102400000064 Neuropeptide Y Human genes 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 101800000590 Obestatin Proteins 0.000 description 1
- 206010029957 Obstruction gastric Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102100029909 Peptide YY Human genes 0.000 description 1
- 108010088847 Peptide YY Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 208000032395 Post gastric surgery syndrome Diseases 0.000 description 1
- 201000000660 Pyloric Stenosis Diseases 0.000 description 1
- 206010039710 Scleroderma Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 229910052770 Uranium Inorganic materials 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 238000007681 bariatric surgery Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000032770 biofilm formation Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 235000020226 cashew nut Nutrition 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 108091008690 chemoreceptors Proteins 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000005786 degenerative changes Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229960004597 dexfenfluramine Drugs 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 206010060865 duodenogastric reflux Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 238000004070 electrodeposition Methods 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000001839 endoscopy Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 229960002179 ephedrine Drugs 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 208000008386 gastric outlet obstruction Diseases 0.000 description 1
- 238000011902 gastrointestinal surgery Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 210000000514 hepatopancreas Anatomy 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 238000002357 laparoscopic surgery Methods 0.000 description 1
- 238000012830 laparoscopic surgical procedure Methods 0.000 description 1
- 229940039781 leptin Drugs 0.000 description 1
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 238000003754 machining Methods 0.000 description 1
- 239000000696 magnetic material Substances 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229920002529 medical grade silicone Polymers 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 239000002991 molded plastic Substances 0.000 description 1
- 208000001022 morbid obesity Diseases 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000003957 neurotransmitter release Effects 0.000 description 1
- 230000019818 neurotransmitter uptake Effects 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- URPYMXQQVHTUDU-OFGSCBOVSA-N nucleopeptide y Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 URPYMXQQVHTUDU-OFGSCBOVSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000002355 open surgical procedure Methods 0.000 description 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 description 1
- 229960001243 orlistat Drugs 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 210000001711 oxyntic cell Anatomy 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 238000009958 sewing Methods 0.000 description 1
- 229960004425 sibutramine Drugs 0.000 description 1
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000476 thermogenic effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000007838 tissue remodeling Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 230000002477 vacuolizing effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 239000013585 weight reducing agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2476—Valves implantable in the body not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0036—Intragastrical devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F5/00—Orthopaedic methods or devices for non-surgical treatment of bones or joints; Nursing devices ; Anti-rape devices
- A61F5/0003—Apparatus for the treatment of obesity; Anti-eating devices
- A61F5/0013—Implantable devices or invasive measures
- A61F5/0076—Implantable devices or invasive measures preventing normal digestion, e.g. Bariatric or gastric sleeves
- A61F5/0079—Pyloric or esophageal obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/04—Surgical instruments, devices or methods for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0409—Instruments for applying suture anchors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/04—Surgical instruments, devices or methods for suturing wounds; Holders or packages for needles or suture materials
- A61B17/0401—Suture anchors, buttons or pledgets, i.e. means for attaching sutures to bone, cartilage or soft tissue; Instruments for applying or removing suture anchors
- A61B2017/0417—T-fasteners
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/064—Surgical staples, i.e. penetrating the tissue
- A61B2017/0649—Coils or spirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/30—Surgical pincettes, i.e. surgical tweezers without pivotal connections
- A61B2017/306—Surgical pincettes, i.e. surgical tweezers without pivotal connections holding by means of suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Nursing (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Surgical Instruments (AREA)
- Prostheses (AREA)
- Percussion Or Vibration Massage (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83941306P | 2006-08-23 | 2006-08-23 | |
| US60/839,413 | 2006-08-23 | ||
| US86080606P | 2006-11-24 | 2006-11-24 | |
| US60/860,806 | 2006-11-24 | ||
| US92486707P | 2007-06-04 | 2007-06-04 | |
| US60/924,867 | 2007-06-04 | ||
| PCT/IL2007/001047 WO2008023374A2 (en) | 2006-08-23 | 2007-08-22 | Devices and methods for altering eating behavior |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2007287201A1 AU2007287201A1 (en) | 2008-02-28 |
| AU2007287201B2 true AU2007287201B2 (en) | 2012-11-15 |
Family
ID=39107209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2007287201A Ceased AU2007287201B2 (en) | 2006-08-23 | 2007-08-22 | Devices and methods for altering eating behavior |
Country Status (6)
| Country | Link |
|---|---|
| US (3) | US8142513B2 (enExample) |
| EP (1) | EP2056741A2 (enExample) |
| JP (1) | JP5191489B2 (enExample) |
| AU (1) | AU2007287201B2 (enExample) |
| CA (1) | CA2661191C (enExample) |
| WO (1) | WO2008023374A2 (enExample) |
Families Citing this family (67)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101268271B1 (ko) | 2004-10-15 | 2013-05-31 | 비에프케이더블유, 엘엘씨 | 배리애트릭 장치 및 방법 |
| DK1933810T3 (da) | 2005-08-11 | 2013-01-28 | Childrens Medical Center | Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde |
| WO2008023374A2 (en) * | 2006-08-23 | 2008-02-28 | Svip 2 Llc | Devices and methods for altering eating behavior |
| EP2111148B1 (en) * | 2007-01-19 | 2015-08-12 | Given Imaging (Los Angeles) LLC | Micro-remote gastrointestinal physiological measurement device |
| CN101686800A (zh) | 2007-02-01 | 2010-03-31 | 普罗秋斯生物医学公司 | 可摄入事件标记器系统 |
| AU2008216170B2 (en) | 2007-02-14 | 2012-07-26 | Otsuka Pharmaceutical Co., Ltd. | In-body power source having high surface area electrode |
| US8529431B2 (en) | 2007-02-14 | 2013-09-10 | Bfkw, Llc | Bariatric device and method |
| US8540632B2 (en) * | 2007-05-24 | 2013-09-24 | Proteus Digital Health, Inc. | Low profile antenna for in body device |
| US8323300B2 (en) | 2007-06-04 | 2012-12-04 | Svip 8 Llc | Tissue anchorable devices |
| US8197504B2 (en) | 2008-05-01 | 2012-06-12 | Ethicon Endo-Surgery, Inc. | Safe tissue puncture device |
| WO2009147670A1 (en) * | 2008-06-03 | 2009-12-10 | Svip 8 Llc | Tissue-anchored devices |
| SG195535A1 (en) | 2008-07-08 | 2013-12-30 | Proteus Digital Health Inc | Ingestible event marker data framework |
| US20100256696A1 (en) * | 2009-04-07 | 2010-10-07 | Boston Scientific Neuromodulation Corporation | Anchoring Units For Implantable Electrical Stimulation Systems And Methods Of Making And Using |
| US8911392B2 (en) | 2009-04-08 | 2014-12-16 | E2, Llc | Systems and methods for treatment of obesity and type 2 diabetes |
| US8403877B2 (en) * | 2009-07-01 | 2013-03-26 | E2 Llc | Systems and methods for treatment of obesity and type 2 diabetes |
| EP2424464A4 (en) * | 2009-04-30 | 2015-04-15 | Svip 2 Llc | DEVICE AND METHOD FOR THE TREATMENT OF STOMACH-DARM AND METABOLISM DISEASES |
| US8414559B2 (en) | 2009-05-07 | 2013-04-09 | Rainbow Medical Ltd. | Gastroretentive duodenal pill |
| US20110066175A1 (en) * | 2009-05-07 | 2011-03-17 | Rainbow Medical Ltd. | Gastric anchor |
| US8574184B2 (en) * | 2009-07-01 | 2013-11-05 | E2 Llc | Systems and methods for treatment of obesity and type 2 diabetes |
| US20110004236A1 (en) * | 2009-07-01 | 2011-01-06 | E2 Llc | Systems and Methods for Treating Obesity and Type 2 Diabetes |
| US8496608B2 (en) * | 2009-07-01 | 2013-07-30 | E2 Llc | Systems and methods for treating obesity and type 2 diabetes |
| US9295574B2 (en) | 2009-07-01 | 2016-03-29 | E2, Llc | Systems and methods for treating obesity and type 2 diabetes |
| US20110004146A1 (en) * | 2009-07-01 | 2011-01-06 | E2 Llc | Systems and Methods for Treating of Obesity and Type 2 Diabetes |
| US8591452B2 (en) * | 2009-07-01 | 2013-11-26 | E2 Llc | Systems and methods for treating obesity and type 2 diabetes |
| TWI517050B (zh) | 2009-11-04 | 2016-01-11 | 普羅托斯數位健康公司 | 供應鏈管理之系統 |
| US8679094B2 (en) | 2009-12-17 | 2014-03-25 | Taris Biomedical, Inc. | Implantable device with intravesical tolerability and methods of treatment |
| TWI557672B (zh) | 2010-05-19 | 2016-11-11 | 波提亞斯數位康健公司 | 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置 |
| US8628554B2 (en) | 2010-06-13 | 2014-01-14 | Virender K. Sharma | Intragastric device for treating obesity |
| US10420665B2 (en) | 2010-06-13 | 2019-09-24 | W. L. Gore & Associates, Inc. | Intragastric device for treating obesity |
| US9526648B2 (en) | 2010-06-13 | 2016-12-27 | Synerz Medical, Inc. | Intragastric device for treating obesity |
| US10010439B2 (en) | 2010-06-13 | 2018-07-03 | Synerz Medical, Inc. | Intragastric device for treating obesity |
| AU2011276449A1 (en) * | 2010-06-29 | 2013-02-14 | Yale University | Tissue retractor assembly |
| US9198791B2 (en) | 2010-07-22 | 2015-12-01 | Endobetix Ltd. | Pancreaticobiliary diversion device |
| PT2600800T (pt) | 2010-08-05 | 2020-11-05 | Taris Biomedical Llc | Dispositivo de administração de drogas por stent ureteral, kit e método |
| US20120245553A1 (en) * | 2011-03-25 | 2012-09-27 | Allergan, Inc. | Intragastric volume occupying device with active agents |
| WO2013003613A2 (en) | 2011-06-28 | 2013-01-03 | Novatract Surgical, Inc. | Tissue retractor assembly |
| WO2015112603A1 (en) | 2014-01-21 | 2015-07-30 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
| US10973513B2 (en) | 2011-09-29 | 2021-04-13 | Ethicon, Llc | Barbed suture having increased holding strength |
| US9149383B2 (en) * | 2012-01-23 | 2015-10-06 | Apollo Endosurgery, Inc. | Endolumenal esophageal restriction device |
| US9456916B2 (en) | 2013-03-12 | 2016-10-04 | Medibotics Llc | Device for selectively reducing absorption of unhealthy food |
| US11672529B2 (en) * | 2012-09-17 | 2023-06-13 | Cilag Gmbh International | Barbed sutures having contoured barbs that facilitate passage through tissue and increase holding strength |
| US9409009B2 (en) * | 2012-11-07 | 2016-08-09 | The Florida International University | Multi-lead multi-electrode management system |
| US9011365B2 (en) | 2013-03-12 | 2015-04-21 | Medibotics Llc | Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food |
| US9067070B2 (en) | 2013-03-12 | 2015-06-30 | Medibotics Llc | Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type |
| SG11201507294WA (en) | 2013-03-15 | 2015-10-29 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
| WO2014197402A1 (en) | 2013-06-04 | 2014-12-11 | Proteus Digital Health, Inc. | System, apparatus and methods for data collection and assessing outcomes |
| CN103340595B (zh) * | 2013-07-03 | 2015-08-26 | 安翰光电技术（武汉）有限公司 | 一种无线胶囊内窥镜及其电源控制方法 |
| US9492396B2 (en) | 2014-07-15 | 2016-11-15 | Yossi Gross | Enhanced drug delivery pill |
| US9795378B2 (en) | 2014-10-31 | 2017-10-24 | Ethicon, Inc. | Method for approximating wounds |
| JP6743041B2 (ja) | 2015-03-30 | 2020-08-19 | タリス バイオメディカル エルエルシー | 上部尿路への薬剤の局所的な送達装置及び方法 |
| WO2016172704A1 (en) | 2015-04-23 | 2016-10-27 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
| US11116658B2 (en) | 2015-06-28 | 2021-09-14 | Oberon Sciences Ilan Ltd. | Devices for gastrointestinal stimulation and uses thereof |
| US10779980B2 (en) | 2016-04-27 | 2020-09-22 | Synerz Medical, Inc. | Intragastric device for treating obesity |
| WO2018018034A1 (en) | 2016-07-22 | 2018-01-25 | Proteus Digital Health, Inc. | Electromagnetic sensing and detection of ingestible event markers |
| US10736566B2 (en) | 2017-02-13 | 2020-08-11 | The Board Of Trustees Of The University Of Alabama | Food intake monitor |
| US10675248B2 (en) | 2018-08-14 | 2020-06-09 | Alma Therapeutics Ltd. | Expandable pill |
| CN109010072B (zh) * | 2018-08-28 | 2021-10-22 | 河南优德医疗设备股份有限公司 | 一种可用于辅助治疗吞咽障碍的自动喂饭机 |
| US12082770B2 (en) * | 2018-09-20 | 2024-09-10 | Nec Corporation | Location estimation apparatus, location estimation method, and computer readable recording medium |
| US11721425B2 (en) | 2019-01-30 | 2023-08-08 | Remmedy, Llc | Method of system for inducing a Pavlovian conditioned association of an aroma with a state of satiation |
| WO2020183399A1 (en) | 2019-03-11 | 2020-09-17 | Bfkw, Llc | Single member intraluminal device and method of fixation |
| EP3946151A4 (en) * | 2019-03-25 | 2022-12-07 | Bfkw, Llc | INTRALUMINAL DEVICE AND METHOD WITH ANTI-MIGRATION |
| US12127958B2 (en) | 2019-03-25 | 2024-10-29 | Bfkw, Llc | Intraluminal device and method with anti-migration |
| EP4048210A4 (en) * | 2019-10-24 | 2024-02-21 | Metamodix, Inc. | SYSTEMS AND METHODS FOR ANCHORING AND RETAINING GASTROINTESTINAL PROSTHESES |
| WO2022051662A1 (en) * | 2020-09-04 | 2022-03-10 | Remmedy, Llc | Method of system for inducing a pavlovian conditioned association of an aroma with a state of satiation |
| WO2023219577A1 (en) * | 2022-05-10 | 2023-11-16 | Yeditepe Universitesi | Small intestinal area reducing device for non-surgical obesity treatment |
| WO2025034591A1 (en) * | 2023-08-10 | 2025-02-13 | Intuitive Surgical Operations, Inc. | Computer assisted stomach volume reduction procedures |
| WO2025199123A1 (en) * | 2024-03-19 | 2025-09-25 | Lyndra Therapeutics, Inc. | Flexible line configurations for gastric residence systems |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6754536B2 (en) * | 2001-01-31 | 2004-06-22 | Medtronic, Inc | Implantable medical device affixed internally within the gastrointestinal tract |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8603099D0 (en) | 1986-02-07 | 1986-03-12 | Blass K G | Gastrointestinal module |
| US5156641A (en) | 1990-03-07 | 1992-10-20 | Mayo Foundation For Medical Education And Research | Naso-gastric catheter anchor system |
| DK0585368T3 (da) | 1991-04-25 | 1998-03-16 | Univ Brown Res Found | Implanterbart biokompatibelt immunisolatorisk vehikel til afgivelse af udvalgte terapeutiske produkter |
| US5185005A (en) | 1991-06-04 | 1993-02-09 | Board Of Regents, The University Of Texas System | Method and apparatus for securing a nasogastric tube |
| US5234454A (en) * | 1991-08-05 | 1993-08-10 | Akron City Hospital | Percutaneous intragastric balloon catheter and method for controlling body weight therewith |
| AU742942B2 (en) | 1997-04-07 | 2002-01-17 | Cook Urological Inc. | Back-up retention member drainage catheter |
| AU2114299A (en) | 1998-01-14 | 1999-08-02 | Conway-Stuart Medical, Inc. | Electrosurgical device for sphincter treatment |
| US7599736B2 (en) | 2001-07-23 | 2009-10-06 | Dilorenzo Biomedical, Llc | Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease |
| US6264700B1 (en) | 1998-08-27 | 2001-07-24 | Endonetics, Inc. | Prosthetic gastroesophageal valve |
| US6231589B1 (en) | 1999-03-22 | 2001-05-15 | Microvena Corporation | Body vessel filter |
| US7615076B2 (en) | 1999-10-20 | 2009-11-10 | Anulex Technologies, Inc. | Method and apparatus for the treatment of the intervertebral disc annulus |
| WO2002087412A2 (en) | 2000-08-07 | 2002-11-07 | Abbeymoor Medical, Inc. | Endourethral device & method |
| US20060069429A1 (en) | 2001-04-24 | 2006-03-30 | Spence Paul A | Tissue fastening systems and methods utilizing magnetic guidance |
| US7756582B2 (en) * | 2001-05-01 | 2010-07-13 | Intrapace, Inc. | Gastric stimulation anchor and method |
| US20070162085A1 (en) * | 2001-07-23 | 2007-07-12 | Dilorenzo Biomedical, Llc | Method, apparatus, surgical technique, and stimulation parameters for autonomic neuromodulation for the treatment of obesity |
| EP1553892A1 (en) | 2002-05-09 | 2005-07-20 | Thomas D. Egan | Gastric bypass prosthesis |
| US6746460B2 (en) | 2002-08-07 | 2004-06-08 | Satiety, Inc. | Intra-gastric fastening devices |
| US20090149871A9 (en) | 2002-11-01 | 2009-06-11 | Jonathan Kagan | Devices and methods for treating morbid obesity |
| US20090259236A2 (en) | 2003-07-28 | 2009-10-15 | Baronova, Inc. | Gastric retaining devices and methods |
| US8048169B2 (en) * | 2003-07-28 | 2011-11-01 | Baronova, Inc. | Pyloric valve obstructing devices and methods |
| US7054690B2 (en) * | 2003-10-22 | 2006-05-30 | Intrapace, Inc. | Gastrointestinal stimulation device |
| US7699818B2 (en) | 2005-02-08 | 2010-04-20 | Paul J. Gilbert | Insertion system and methods for nasogastric tubes |
| US7805195B2 (en) | 2005-03-24 | 2010-09-28 | Vanderbilt University | Respiratory triggered, bilateral laryngeal stimulator to restore normal ventilation in vocal fold paralysis |
| US8216158B2 (en) | 2005-07-20 | 2012-07-10 | Medtronic, Inc. | Implantation of a medical device within a lumen |
| US8070768B2 (en) | 2006-04-19 | 2011-12-06 | Vibrynt, Inc. | Devices and methods for treatment of obesity |
| US7909037B2 (en) | 2006-04-20 | 2011-03-22 | Pavad Medical | Tethered airway implants and methods of using the same |
| US8038712B2 (en) | 2006-06-29 | 2011-10-18 | Koninklijke Philips Electronics N.V. | Methods and devices for rhinoplasty and treating internal valve stenosis |
| WO2008023374A2 (en) | 2006-08-23 | 2008-02-28 | Svip 2 Llc | Devices and methods for altering eating behavior |
| US8136532B2 (en) | 2006-08-30 | 2012-03-20 | Med-El Elektromedizinische Geraete Gmbh | System, apparatus, and method for facilitating interface with laryngeal structures |
| US20080221599A1 (en) * | 2007-03-06 | 2008-09-11 | Starksen Niel F | Devices, methods, and kits for gastrointestinal procedures |
| WO2008132745A2 (en) | 2007-04-30 | 2008-11-06 | Spatz Fgia, Inc. | Non-endoscopic insertion and removal of a device |
| US8323300B2 (en) | 2007-06-04 | 2012-12-04 | Svip 8 Llc | Tissue anchorable devices |
| EP2254462B1 (en) * | 2007-11-12 | 2015-05-20 | Daniel J. Dilorenzo | Apparatus for programming of autonomic neuromodulation for the treatment of obesity |
| US8657879B2 (en) | 2007-12-05 | 2014-02-25 | Svip 7 Llc | Devices and methods for treating sleep disordered breathing |
| WO2009147670A1 (en) | 2008-06-03 | 2009-12-10 | Svip 8 Llc | Tissue-anchored devices |
-
2007
- 2007-08-22 WO PCT/IL2007/001047 patent/WO2008023374A2/en not_active Ceased
- 2007-08-22 US US12/310,359 patent/US8142513B2/en not_active Expired - Fee Related
- 2007-08-22 EP EP07805507A patent/EP2056741A2/en not_active Withdrawn
- 2007-08-22 CA CA2661191A patent/CA2661191C/en not_active Expired - Fee Related
- 2007-08-22 JP JP2009525171A patent/JP5191489B2/ja not_active Expired - Fee Related
- 2007-08-22 AU AU2007287201A patent/AU2007287201B2/en not_active Ceased
-
2012
- 2012-03-05 US US13/411,696 patent/US8540780B2/en not_active Expired - Fee Related
-
2013
- 2013-07-30 US US13/953,751 patent/US8999002B2/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6754536B2 (en) * | 2001-01-31 | 2004-06-22 | Medtronic, Inc | Implantable medical device affixed internally within the gastrointestinal tract |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008023374A3 (en) | 2009-04-30 |
| EP2056741A2 (en) | 2009-05-13 |
| AU2007287201A1 (en) | 2008-02-28 |
| JP5191489B2 (ja) | 2013-05-08 |
| US20090247992A1 (en) | 2009-10-01 |
| WO2008023374A2 (en) | 2008-02-28 |
| CA2661191A1 (en) | 2008-02-28 |
| JP2010501242A (ja) | 2010-01-21 |
| CA2661191C (en) | 2014-12-02 |
| US8540780B2 (en) | 2013-09-24 |
| US20120165855A1 (en) | 2012-06-28 |
| US8142513B2 (en) | 2012-03-27 |
| US8999002B2 (en) | 2015-04-07 |
| US20130317414A1 (en) | 2013-11-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2007287201B2 (en) | Devices and methods for altering eating behavior | |
| US20240082034A1 (en) | Delivery devices and methods for gastrointestinal implants | |
| US20120041465A1 (en) | Devices and methods for treating gastrointestinal and metabolic disorders | |
| US7881797B2 (en) | Methods and devices for gastrointestinal stimulation | |
| US8323300B2 (en) | Tissue anchorable devices | |
| US8636751B2 (en) | Methods and devices for the rerouting of chyme to induce intestinal brake | |
| US7837669B2 (en) | Devices and methods for endolumenal gastrointestinal bypass | |
| AU2012315575B2 (en) | Delivery devices and methods for gastrointestinal implants | |
| US20090118749A1 (en) | Pyloric Devices and Methods | |
| US20140114432A1 (en) | Tissue anchorable devices | |
| IL197198A (en) | Devices for altering eating behavior |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |